Major Drugs - McLean, VA, US
KeifeRx is an emerging clinical-stage biopharmaceutical company developing novel and optimized, low dose, orally delivered tyrosine kinase inhibitors (TKIs) for the treatment of multiple, high-need neurodegenerative and immune diseases.
Outlook
Varnish
Amazon AWS
Mobile Friendly